Background: Pollen of Bahia grass (Paspalum notatum) represents a major cause of type I allergy in diverse geographical areas, particularly in the southeastern coastal plain area of the United States. The aqueous protein extract of Bahia grass pollen contains the allergenically active components that produce skin-test-positive reactions in sensitive patients. Objective: The emphasis of this study included the identification and characterization of the allergenic proteins present in the crude protein aqueous extract of Bahia grass pollen. Methods: The crude extract of Bahia grass pollen, partially purified by isoelectric focusing and fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), was electroblotted onto nitrocellulose membranes, probed with sera from patients skin test positive to Bahia grass and detected using anti-human IgE conjugated peroxidase. Results: Four allergenic proteins of Bahia grass pollen with estimated molecular weights of 45, 33, 31 and 28 kD were identified and characterized. Following treatments with deglycosylation enzymes, the 4 allergens retained their antigenic reactivity with Bahia-grass-allergic patient sera containing polyclonal IgE antibodies. Conclusion: The crude extract of Bahia grass pollen contains many proteins but only 4 have allergenic reactivity. Following deglycosylation treatment, Bahia grass allergenic proteins have retained their antigenic reactivity with Bahia-grass-allergic patient sera containing polyclonal IgE antibodies. Four proteins reactive with IgE were detected, but the 33-kD protein (pI of 6.59) was the most reactive.

Keywords:
Bahia grass, Pollen allergens, IgE, SDS-PAGE, Immunoblotting, Deglycosylation
1.
Phillip JW, Goldman AL, Lockey RF: Bahia grass pollen – an important aeroallergen. J Allergy Clin Immunol 1979;63:192–193.
2.
Chase A: Revision of the Hitchcocks Manual of Grasses of the United States. US Dept of Agriculture Miscel Publication 200, 1995, p 605.
3.
Martin BG, Mansfield LE, Nelson HS: Cross-allergenicity among the grasses. Ann Allergy 1985;54:99–104.
4.
Sweeny M, Hosseiny S, Hunter S, Klotz SD, Gennaro RN, White RS: Immunodetection and comparison of Melaluca, Bottlebrush, and Bahia pollens. Int Arch Allergy Appl Immunol 1994;105:289–296.
5.
Baldo BA: Standardization of allergens, examination of existing procedures and the likely impact of new techniques on the quality control of extracts. Allergy 1983;38:535–546.
6.
Tovey ER, Baldo BA: Characterization of allergens by protein blotting. Electrophoresis 1987;8:452–463.
7.
King TP, Norman PS: Isolation studies of allergens from ragweed pollen. Biochemistry 1962;1:709–720.
8.
King TP: Chemical and biological properties of some atopic allergens. Adv Immunol 1976;23:77–105.
9.
Egen NB, Bliss M, Mayersohn M, Owens SM, Arnold L, Bier M: Isolation of monoclonal antibodies to phencyclidine from ascites fluid by preparative isoelectric focusing in the rotofor. Biochemistry 1998;172:488–494.
10.
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
11.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
12.
Timmones TM, Dunbar TB: Protein blotting and immunodetection. Methods Immunol 1990;182:679–688.
13.
Rodriguez NM, Gennaro R, Klotz S, Sweeney M, White R: Purification of pollen allergens using the Bio-Rad Rotofor and Model 491 Prep Cell. Bio Radiat 2000;104:22–23.
14.
Ghobrial GI: Molecular cloning, expression and characterization of the major allergen, Pas n 1, of Bahia grass (Paspalum notatum) pollen; MSc thesis University of Central Florida, Orlando 1999.
15.
Hunter SL: Isolation and partial purification of allergenic components of the pollen Paspalum notatum and Melaleuca leucadendron; MSc thesis University of Central Florida, Orlando 1993.
16.
Becker WM, Bufe A, Petersen A, Schlaak M: Molecular characterization of timothy grass pollen group V allergens. Int Arch Allergy Immunol 1995;107:242–244.
17.
Petersen A, Bufe A, Schlaak M, Becker WM: Characterization of the allergen group VI in timothy grass pollen (Phl p 6) I. Immunological and biochemical studies. Int Arch Allergy Immunol 1995;108:49–54.
18.
Ford SA, Baldo BA: A re-examination of ryegrass (Lolium perenne) pollen allergens. Int Arch Allergy Appl Immunol 1986;81:193–203.
19.
Johnson P, Marsh DG: The isolation and characterization of allergen from the pollen of ryegrass (Lolium perenne). Eur Polym J 1965;1:63–77.
20.
White JM, Majidi A, Naser S, Sweeney MJ, White RS, Petersen A: Cross-reactivity of Bahia (Paspalum notatum) and timothy (Phleum pratense) grass pollens. J Allergy Clin Immunol 2001;107:50.
21.
Tamborini E, Brandazza A, De Lalla C, Musco G, Siccardi AG, Arosio P, Sidoli A: Recombinant allergen Lol p II expression, purification and characterization. Mol Immunol 1995;32:505–513.
22.
Vailes LD, Kinter MT, Arruda LK, Chapman MD: High level expression of cockroach allergen, Bla g 4, in Pichia pastoris. J Allergy Clin Immunol 1998;101:274–280.
23.
Valenta R, Duchane M, Pettenbuger K: Identification of profiling as novel pollen allergen: IgE autoreactivity in sensitized patients. Science 1991;253:557–560.
24.
Rafnar T, Griffith U, Kuo M, Bend JF, Rogers BL, Klapper DG: Cloning of Amb a 1 (antigen E), the major allergen family of short ragweed pollen. J Biol Chem 1991;266:1220–1236.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.